Eversana is increasing its reach across the global pharmaceutical industry. With the opening of its first office in Germany, the provider of commercialization services now has a presence in four of the world’s five biggest pharma markets.
The new office is located in Berlin, according to Eversana’s announcement Monday. From there, the company will be able to offer its services—spanning support for drug pricing, access, promotion and delivery—throughout the region.
“Over the years we have made smart strategic investments in the services, talent, and locations needed to transform the global commercialization of life-changing therapies. Germany represents the fourth-largest pharmaceutical market in the world and is often the first country in which our clients strategically launch new therapies in Europe,” Eversana CEO Jim Lang said in a statement, adding, “We have the local expertise and operations in Germany to help our clients and their products thrive.”
The expansion into Germany is the latest of Eversana’s moves to strengthen its foothold in Europe. In another deal late last year, the company moved to acquire one of its long-term E.U. partners, Healthware Group, a full-service agency and consultancy headquartered in Salerno, Italy. Before that, in 2022, Eversana opened its first office in the U.K.
As the company noted in this week’s release, the Berlin office’s opening comes just in time for Eversana’s hosting and sponsorship of the annual Frontiers Health conference, which is set to take place in the German city later this month.
Outside of the recently established U.K. and Germany offices, Eversana’s European presence includes locations in Italy and Finland. The U.S.-based company also maintains nearly two dozen offices across the U.S. and Canada, plus a few more scattered throughout Asia and Australia.